𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Facts and uncertainties in monitoring treatment response in chronic myeloid leukaemia

✍ Scribed by Richard E. Clark


Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
138 KB
Volume
33
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Therapeutic targets in chronic myeloid l
✍ Nicholas B. Heaney; Tessa L. Holyoake πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 162 KB

## Abstract Chronic myeloid leukaemia (CML) is a clonal disorder of the haemopoietic stem cell arising as a consequence of the formation of the __bcr‐abl__ oncogene. The particular molecular basis of this condition has enabled the development of therapies that selectively target diseased cells. The

Oral idarubicin in the treatment of acut
✍ S. T. A. Malik; J. Tucker; A. Z. S. Rohatiner; W. Brace; T. A. Lister πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 307 KB

Fourteen patients with poor-risk acute myelogenous leukaemia (AML) and five patients with accelerated phase/blast crisis chronic myeloid leukaemia (CML) were treated with 3 days of oral idarubicin (25 mg/m2/ day). No complete remissions or return to chronic phase CML were observed. A fall in the per

P108 Central nervous system blastic phas
✍ A. Kiss; A. Ujfalusy; T. Csepany; Gy. Remenyi; P. Batar; E. Balogh; M. Udvardy πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 51 KB

6/155), high white cell number (13/155) (red cell unit) or low thrombocyte number (14/125) (thrombocyte unit). Summary: Donors with low hemoglobin levels have to be excluded from the blood donation service for 3 months. So, in theory haemoglobin concentration of all total blood units is suitable for

CD7 expression on CD34+ cells from chron
✍ MartοΏ½n-Henao, G.A.; Quiroga, R.; Sureda, A.; GarcοΏ½a, J. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 100 KB πŸ‘ 1 views

Thirty-seven patients with chronic phase chronic myeloid leukaemia and fourteen healthy controls have been evaluated for lineage differentiation with immunological markers on purified bone marrow CD34 positive cells by multiparameter flow cytometry. The myeloidassociated antigen CD33 and the stem ce